A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: accurate review of management and perspectives

The Globocan 2012 asserted that cancer of the esophagus is the eighth most common cancer worldwide, sixth for mortality, with approximately 496,000 cases in 2015. Less developed countries are most likely to develop this disease (80%), although incidence is truly variable worldwide [1]. Despite the fact that the survival rate has been slowly increasing in the U.S.A. by around 0.7% per year (2002-2012), perhaps after the adhesion to multimodality techniques for treatment and improved supportive care, the worldwide survival rate has not been superior to 18.8% at 5 years yet [2].

Source: Critical Reviews in Oncology Hematology - October 12, 2018 Category: Cancer & Oncology Authors: Antonio Chiappa, Bruno Andreoni, Renzo Dionigi, Lorenzo Spaggiari, Diego Foschi, Gianluca Polvani, Roberto Orecchia, Nicola Fazio, Gabriella Pravettoni, Maria Laura Cossu, Domenico Galetta, Marco Venturino, Carlo Ferrari, Lorenzo Macone, Cristiano Crosta, Source Type: research